首页> 外文期刊>Biotechnology Journal: Healthcare,Nutrition,Technology >Malaria vaccine candidate antigen targeting the pre-erythrocytic stage of Plasmodium falciparum produced at high level in plants
【24h】

Malaria vaccine candidate antigen targeting the pre-erythrocytic stage of Plasmodium falciparum produced at high level in plants

机译:靶向植物中高水平产生的恶性疟原虫红细胞前阶段的疟疾疫苗候选抗原

获取原文
获取原文并翻译 | 示例
           

摘要

Plants have emerged as low-cost production platforms suitable for vaccines targeting poverty-related diseases. Besides functional efficacy, the stability, yield, and purification process determine the production costs of a vaccine and thereby the feasibility of plant-based production. We describe high-level plant production and functional characterization of a malaria vaccine candidate targeting the pre-erythrocytic stage of Plasmodium falciparum. CCT, a fusion protein composed of three sporozoite antigens (P. falciparum cell traversal protein for ookinetes and sporozoites [PfCelTOS], P. falciparum circumsporozoite protein [PfCSP], and P. falciparum thrombospondin-related adhesive protein [PfTRAP]), was transiently expressed by agroinfiltration in Nicotiana benthamiana leaves, accumulated to levels up to 2 mg/g fresh leaf weight (FLW), was thermostable up to 80 degrees C and could be purified to >95% using a simple two-step procedure. Reactivity of sera from malaria semi-immune donors indicated the immunogenic conformation of the purified fusion protein consisting of PfCelTOS, PfCSP_TSR, PfTRAP_TSR domains (CCT) protein. Total IgG from the CCT-specific mouse immune sera specifically recognized P. falciparum sporozoites in immunofluorescence assays and induced up to 35% inhibition in hepatocyte invasion assays. Featuring domains from three promising sporozoite antigens with different roles (attachment and cell traversal) in the hepatocyte invasion process, CCT has the potential to elicit broader immune responses against the pre-erythrocytic stage of P. falciparum and represents an interesting new candidate, also as a component of multi-stage, multi-subunit malaria vaccine cocktails.
机译:植物已经成为适合于针对贫困相关疾病的疫苗的低成本生产平台。除了功能功效之外,稳定性,产量和纯化过程还决定了疫苗的生产成本,从而决定了基于植物的生产的可行性。我们描述了针对恶性疟原虫的前红细胞生成阶段的疟疾候选疫苗的高级植物生产和功能表征。 CCT,一种融合蛋白,由三种子孢子抗原组成(用于钩子和子孢子的恶性疟原虫细胞穿越蛋白[PfCelTOS],恶性疟原虫环孢子蛋白[PfCSP]和恶性疟原虫血小板反应蛋白相关的粘附蛋白[PfTRAP])通过农杆菌渗入在本氏烟草叶片中表达,积累至高达2 mg / g新鲜叶片重量(FLW)的水平,在高达80摄氏度的温度下都是热稳定的,并且可以使用简单的两步程序将其纯化至> 95%。来自疟疾半免疫供体的血清反应性表明,由PfCelTOS,PfCSP_TSR,PfTRAP_TSR域(CCT)蛋白组成的纯化融合蛋白具有免疫原性。来自CCT特异性小鼠免疫血清的总IgG在免疫荧光测定法中特异性识别恶性疟原虫子孢子,并在肝细胞侵袭测定法中诱导高达35%的抑制作用。 CCT具有在肝细胞侵袭过程中具有不同作用(附着和细胞穿越)的三种有希望的子孢子抗原的结构域,CCT有可能引发针对恶性疟原虫前阶段的更广泛的免疫反应,并且代表了一个有趣的新候选者,多阶段,多亚基疟疾疫苗鸡尾酒的组成部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号